This suggests TRPC5’s potential as a marker for 5-FU resistance in CRC, influencing the expression of downstream drug resistance proteins like ATP-binding cassette subfamily B1 (ABCB1) and glucose transporter 1 (GLUT1) [40,41]. The gene discussed is TRPC5; the disease is colorectal carcinoma.